| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.009 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.15 | 0.02 |